NEW YORK (GenomeWeb) – BioMérieux said today that its first quarter revenues rose 3 percent year over year, driven by an intense flu season and growth in the Asia Pacific region.

BioMérieux also announced today that it has submitted a 510(k) application to the US Food and Drug Administration for its BioFire FilmArray Pneumonia Panel.

For the three months ended March 31, the company reported revenues of €587 million ($726.6 million), up from €568 million in the prior-year period. At a constant exchange rates and scope of consolidation, revenues grew 13 percent year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

Feb
26
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease. 

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.